Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

AURA Aura Biosciences Inc

8,20

0,09 (1,11%)

21 Déc 2024 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The sales reported on this Form 144 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Date of Notice

11/18/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Amy Elazzouzi, as Attorney-in-Fact

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Aura Biosciences (NASDAQ:AURA)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024

Plus de graphiques de la Bourse Aura Biosciences

Aura Biosciences (NASDAQ:AURA)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024

Plus de graphiques de la Bourse Aura Biosciences

Actualités Aura Biosciences Inc

Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Mardi 26 Novembre 2024 ( il y a 4 semaines) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 19 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mardi 19 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jeudi 14 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mardi 12 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Mardi 12 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
Mardi 12 Novembre 2024 ( il y a 1 mois) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Vendredi 8 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercredi 30 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercredi 30 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercredi 30 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 30 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Plus d'articles sur Aura Biosciences Inc

Credit Agricole

Lvmh Moet Hennessy Louis...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales